Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRiverside University Health System Medical Center

About this trial

This study is evaluating whether Steri-Strips® provide additional benefits when used after cesarean section (C-section) surgery. Steri-Strips are adhesive strips that are commonly placed over a surgical incision to provide support while the wound heals. At our hospital, Steri-Strips are routinely used after C-sections in addition to standard wound closure techniques, although they are not considered part of the standard recommended closure method.

Researchers want to determine whether adding Steri-Strips actually reduces wound complications such as infection, fluid collection under the skin, or reopening of the incision. Previous studies have shown mixed results, with some suggesting little difference in wound healing outcomes while others reported differences in scar appearance. Steri-Strips may also increase costs, add time to the surgery, and occasionally cause skin irritation or allergic reactions.

Participants in this study will be randomly assigned to one of two groups. One group will receive standard cesarean wound closure with Steri-Strips, while the other group will receive standard wound closure without Steri-Strips. Researchers will compare wound healing, complications, patient outcomes, and costs between the two groups.

The goal of this study is to determine whether Steri-Strips improve recovery after cesarean delivery and whether their routine use is beneficial and cost-effective. The findings may help guide future recommendations for cesarean wound care and improve outcomes for patients undergoing C-section delivery.

Eligibility criteria

Qualifiers

Female patients age 18 years or older

Pregnant patients undergoing cesarean delivery at Riverside University Health System Medical Center (RUHS)

Able and willing to provide informed consent

Disqualifiers

Known allergy or hypersensitivity to Steri-Strip™ materials or adhesives

Inability or unwillingness to provide informed consent

Anticipated inability to complete the 30-day postpartum follow-up evaluation

Trial design

Treatments tested in this trial

  • Steri-Strip™ Skin Closures
  • Standard Cesarean Wound Closure

Treatment groups

610 Participants
are divided into 2 treatment groups